ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China
· Delayed Price · Currency is CNY 29.12
+0.82 (2.90%)
Apr 25, 2025, 2:45 PM CST
ChengDu ShengNuo Biotec Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 80.48 | 49.84 | 70.34 | 64.48 | 61.25 | 60 | Upgrade
|
| Depreciation & Amortization | 34.56 | 34.56 | 27.65 | 24.69 | 18.26 | 17.07 | Upgrade
|
| Other Amortization | 1.19 | 1.19 | 1.49 | 1.27 | 0.49 | 0.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.91 | 0.39 | 4.89 | 0.32 | Upgrade
|
| Asset Writedown & Restructuring Costs | 11.31 | 11.31 | - | - | - | 7.33 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.72 | -1.72 | 1.42 | -2.48 | -1.51 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.32 | 2.46 | 0.86 | - | Upgrade
|
| Other Operating Activities | -15.58 | 18.37 | 16.41 | 6.33 | 2.52 | 0.14 | Upgrade
|
| Change in Accounts Receivable | -49.96 | -49.96 | 9.82 | -22.22 | -17.6 | -8.52 | Upgrade
|
| Change in Inventory | -120.11 | -120.11 | -63.79 | -38.72 | -12.54 | -9.61 | Upgrade
|
| Change in Accounts Payable | 83.04 | 83.04 | 18.64 | 57.6 | -5.28 | 13.72 | Upgrade
|
| Change in Other Net Operating Assets | 4.21 | 4.21 | 2.85 | 1.12 | 1.11 | 1.11 | Upgrade
|
| Operating Cash Flow | 21.98 | 25.27 | 84.78 | 95.62 | 52.41 | 80.84 | Upgrade
|
| Operating Cash Flow Growth | -72.39% | -70.19% | -11.34% | 82.44% | -35.17% | 161.47% | Upgrade
|
| Capital Expenditures | -224.8 | -247.48 | -277.98 | -135.85 | -64.22 | -51.96 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.05 | 0.33 | 0.13 | 0.11 | 0.18 | Upgrade
|
| Investment in Securities | -9.51 | -16.55 | -93.4 | 152.3 | -209.9 | - | Upgrade
|
| Other Investing Activities | 77.77 | 33.15 | 1.75 | 4.38 | -7.9 | - | Upgrade
|
| Investing Cash Flow | -156.5 | -230.83 | -369.31 | 20.96 | -281.91 | -51.78 | Upgrade
|
| Long-Term Debt Issued | - | 302.58 | 216.7 | 100 | 30 | - | Upgrade
|
| Total Debt Issued | 325.26 | 302.58 | 216.7 | 100 | 30 | - | Upgrade
|
| Long-Term Debt Repaid | - | -81.36 | -57.94 | -30.93 | -1.93 | -0.32 | Upgrade
|
| Total Debt Repaid | -158.26 | -81.36 | -57.94 | -30.93 | -1.93 | -0.32 | Upgrade
|
| Net Debt Issued (Repaid) | 167 | 221.22 | 158.75 | 69.07 | 28.07 | -0.32 | Upgrade
|
| Issuance of Common Stock | 6.58 | 6.58 | - | - | 310 | - | Upgrade
|
| Common Dividends Paid | -35.61 | -34.17 | -29.18 | -26.82 | -0.03 | - | Upgrade
|
| Other Financing Activities | -1.07 | -1.13 | 0.18 | - | -25.85 | -3.32 | Upgrade
|
| Financing Cash Flow | 136.91 | 192.51 | 129.75 | 42.25 | 312.2 | -3.64 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.48 | 0.68 | 0.5 | 3 | -0.67 | -0.12 | Upgrade
|
| Net Cash Flow | 2.87 | -12.37 | -154.27 | 161.83 | 82.04 | 25.31 | Upgrade
|
| Free Cash Flow | -202.82 | -222.2 | -193.2 | -40.23 | -11.81 | 28.89 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 38196.35% | Upgrade
|
| Free Cash Flow Margin | -37.81% | -48.72% | -44.41% | -10.17% | -3.06% | 7.63% | Upgrade
|
| Free Cash Flow Per Share | -1.77 | -1.95 | -1.70 | -0.36 | -0.12 | 0.34 | Upgrade
|
| Cash Income Tax Paid | 24.34 | 29.95 | 7.42 | 17.54 | 34.69 | 37.69 | Upgrade
|
| Levered Free Cash Flow | -246.85 | -222.51 | -250.52 | -83.39 | -50.55 | 1.74 | Upgrade
|
| Unlevered Free Cash Flow | -246.85 | -222.51 | -244.84 | -81.36 | -50.45 | 1.75 | Upgrade
|
| Change in Net Working Capital | 138.19 | 65.47 | 48.87 | 13.23 | 47.16 | -0.28 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.